About this trial

The primary aim of this project is to investigate how active screening and the timing of diagnosis affect the long-term health outcomes of patients with celiac disease. Additionally, the study seeks to clarify the natural course of so-called potential celiac disease. A key focus is also placed on assessing adherence to a gluten-free diet among screen-detected and, if initiated, potential celiac disease patients, their satisfaction with the diagnosis, and the diet's impact on general health and quality of life.

Eligibility criteria

Qualifiers

Finnish citizenship and current residence in Finland

Disqualifiers

Age <18 years

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

250 Participants
are grouped into 2 trial groups

Locations

1
Tampere University, Faculty of Medicine and Health Technology33520, Tampere Finland

Sponsors and collaborators

Tampere University Hospital

Lead sponsor

Tampere University

Collaborator

Finnish Medical Foundation

Collaborator